Telehealth hormone therapy has exploded. Prescriptions for testosterone cypionate alone doubled between 2019 and 2024, and an estimated 325 new clinics with multiple locations opened since early 2024. For women, the FDA’s November 2025 removal of the black box warning from menopausal hormone therapy has driven even more interest in online prescribing. The convenience is obvious. But convenience without clinical rigor is not healthcare. It is a gamble with your endocrine system.
The uncomfortable truth is that many online hormone therapy clinics are built around volume, not outcomes. They exist to move prescriptions as fast as possible with as little overhead as possible. Some will prescribe hormones based on a questionnaire alone, with no lab work, no follow-up, and a different provider every time you call. That model is not just substandard. It is genuinely dangerous.
This is not an argument against telehealth. Telehealth done well can deliver better, more accessible care than many traditional office visits. The question is how to tell the difference between a clinic that uses telehealth to improve care and one that uses it to cut corners.
What Happened When a Urologist Went Undercover at Online Testosterone Clinics
In a study led by Northwestern University, urologist Dr. Justin Dubin posed as a healthy 34-year-old seeking testosterone therapy. His testosterone level was 675 ng/dL, well above the threshold for treatment and within normal range by any clinical standard. He also told each clinic he wanted to have children in the future, which matters because exogenous testosterone suppresses sperm production and can cause infertility.
Six out of seven online clinics prescribed him testosterone anyway.
Think about that for a moment. A man with normal hormone levels, actively planning for a family, was handed a prescription that could make him infertile by six out of seven providers. None of those clinics had any clinical justification to prescribe. The American Urological Association and the Endocrine Society both set clear criteria: testosterone therapy is indicated for men with confirmed low testosterone supported by symptoms and repeated lab values. A single online questionnaire does not meet that standard.
As Dr. Dubin noted, telehealth offers real benefits, including access to care and helping men with health issues that carry stigma. But the study exposed a structural problem with the way many online clinics operate. The incentive is to prescribe, not to evaluate.
Why Is Prescribing Hormones Without Proper Lab Work Dangerous?
Hormones are not supplements. They are powerful signaling molecules that affect virtually every system in your body, from cardiovascular function to bone density to mental health. Prescribing them without comprehensive lab work is like adjusting the dosage on a medication you have never measured the baseline for. You are flying blind.
The Polycythemia Problem
One of the most concrete dangers of unmonitored testosterone therapy is polycythemia, a condition where your body produces too many red blood cells. Research published in the Journal of Urology found that men who develop polycythemia while on testosterone therapy face a significantly higher risk of major adverse cardiovascular events and venous thromboembolism in the first year alone. Estimates for this complication range from 5% to 66% of men receiving testosterone therapy, depending on the dosing protocol and patient population.
Catching polycythemia requires a simple blood test. Hematocrit and hemoglobin levels should be checked before starting therapy and again at 3 to 6 months. Without that monitoring, a dangerous elevation in red blood cell concentration can go undetected until it causes a stroke, a pulmonary embolism, or a heart attack.
A clinic that does not order follow-up labs is not saving you time. It is skipping the safety checks that exist for a reason.
Hormonal Cascading Effects
Hormones do not operate in isolation. Adjusting one affects others. Testosterone can convert to estrogen through a process called aromatization. Without monitoring estradiol levels alongside testosterone, a man on TRT can develop symptoms of estrogen excess, including water retention, mood changes, and gynecomastia. For women, prescribing estrogen without evaluating progesterone, thyroid function, cortisol, and insulin markers can create imbalances that worsen the very symptoms the therapy was supposed to treat.
This is why a comprehensive biomarker analysis matters so much. Hormone optimization is not about pushing a single number higher. It is about understanding how the entire hormonal system interacts and calibrating a personalized protocol to the individual.
The Real Problem With Most Online Hormone Therapy Clinics
The business model of high-volume telehealth clinics creates three specific failure points that directly compromise patient safety.
You Talk to a Different Person Every Time
Many online clinics rotate providers. You might speak with one nurse practitioner for your initial consultation, a different physician assistant for your follow-up, and a third provider if you call with a concern. Nobody has the full picture. Nobody knows your history, your responses, or the nuances of how your body is adapting to the protocol. Clinical decision-making suffers when continuity of care does not exist.
Hormone optimization is not a one-and-done prescription. It is an ongoing process of adjustment based on how you feel, how your labs trend, and how your body responds over weeks and months. That requires a provider who knows you.
The Consultation Feels Like a Sales Call
When a clinic’s revenue depends on converting consultations into prescriptions, the clinical evaluation gets compressed. A CBS News investigation found that telehealth sites were promoting testosterone for indications not on the FDA label, including vague claims about “male menopause,” despite an FDA ban on off-label advertising. When the incentive is to prescribe rather than to properly assess, patients receive treatments they may not need and miss diagnoses for conditions that are actually causing their symptoms.
Fatigue, low libido, brain fog, and weight gain are not always hormone problems. They can be thyroid dysfunction, insulin resistance, sleep apnea, depression, or nutritional deficiencies. A thorough provider rules those out. A prescription mill skips that step.
No Meaningful Follow-Up Exists
The most dangerous phase of hormone therapy is not the first prescription. It is the first 90 days. Your body is adjusting to exogenous hormones, and the initial dosing is always an educated estimate. Without follow-up labs at 6 to 8 weeks and again at 12 weeks, there is no way to know whether the dose is appropriate, whether side effects are developing, or whether the treatment is actually working at the physiological level.
A 2021 study in the International Journal of Impotence Research found that pre-treatment blood work is often not performed at online clinics, and clinical guidelines are frequently not followed. That leaves a large population receiving hormone therapy who are essentially unmonitored, falling outside the safety data that clinical trials produce.
How to Evaluate an Online Hormone Therapy Clinic: What to Look For
Not all telehealth is the same. The delivery method (video call versus office visit) matters far less than the clinical process behind it. Here is what separates responsible telehealth hormone therapy from the clinics cutting corners.
| What to Evaluate | Red Flag Clinic | Responsible Clinic |
| Initial Lab Work | Questionnaire only, or single-test panel | Comprehensive biomarker panel before any prescription |
| Provider Continuity | Different provider each visit | Same provider every time who knows your history |
| Follow-Up Labs | Optional or patient-initiated only | Required at 6-8 weeks and 12 weeks minimum |
| Consultation Length | 5-10 minutes, focused on prescribing | 30-45 minutes, reviewing labs and symptoms in detail |
| Provider Accessibility | Support ticket or chatbot only | Direct call or text access to your provider |
| Protocol Adjustments | Standard dose, rarely adjusted | Adjusted based on labs, symptoms, and ongoing feedback |
| Compound Sourcing | Unclear or offshore sourcing | USA-sourced, compounding pharmacy verified |
| Symptom Evaluation | Hormones prescribed for any complaint | Differential diagnosis rules out non-hormonal causes first |
| Pricing Transparency | Low upfront, hidden fees for labs and follow-ups | Clear membership pricing that includes labs and monitoring |
What Does Safe Telehealth Hormone Therapy Actually Look Like?
The clinics getting it right share a common thread: they use telehealth to increase accessibility without sacrificing clinical standards. The technology removes geographic barriers and scheduling friction. It does not remove the obligation to practice evidence-based medicine.
A responsible telehealth hormone therapy process should work like this:
Step 1: A real conversation, not a questionnaire. Your first interaction should be a substantive call with the provider who will manage your care. Not a sales rep. Not a patient coordinator who reads from a script. The actual clinician. This is where your medical history, symptoms, lifestyle, and goals get discussed in detail. Fifteen to twenty minutes minimum, though many cases warrant longer.
Step 2: Comprehensive lab work before any prescription. A complete biomarker analysis should be ordered before hormones are considered. For men, that means total and free testosterone, estradiol, SHBG, PSA, complete blood count, comprehensive metabolic panel, lipid panel, thyroid markers, and more. For women, the panel expands to include progesterone, DHEA-S, and additional metabolic markers. These labs are drawn at a local lab near you. There is no shortcut here. If a provider is willing to prescribe based on symptoms alone, that is your exit sign.
Step 3: A detailed results review with your provider. Once labs return, you sit down (virtually) with your provider for 30 to 45 minutes to go through every result. Not just the hormone numbers, but the metabolic picture, the thyroid function, the inflammatory markers. The protocol that gets built from this conversation is personalized to your body, not a template pulled from a dropdown menu.
Step 4: Ongoing monitoring with the same provider. Follow-up labs at 6 to 8 weeks. A check-in call at 4 to 6 weeks to assess how you are feeling. Another round of labs at 12 weeks. Dosage adjustments based on data, not guesswork. And critically, all of this happens with the same provider who has been managing your care from day one. They know your baseline. They know your trajectory. They know you.
This is what concierge telehealth looks like. It is the opposite of the high-volume, low-touch model that dominates the online hormone therapy space.
The Cardiovascular Safety Data Reinforces Why Monitoring Matters
The 2023 TRAVERSE trial, published in the New England Journal of Medicine, was the largest randomized controlled trial ever conducted on testosterone therapy safety. It enrolled 5,246 men aged 45 to 80 with confirmed hypogonadism and preexisting or high risk of cardiovascular disease. The primary finding was reassuring: testosterone replacement therapy did not increase the rate of major adverse cardiovascular events compared to placebo.
But there is an important caveat that most online clinics do not mention. The trial also found a higher incidence of nonfatal arrhythmias in the testosterone group, with atrial fibrillation occurring in 5.2% of treated men compared to 3.3% on placebo. The trial also demonstrated the importance of proper patient selection, as every participant had confirmed hypogonadism through lab testing and clinical evaluation.
The TRAVERSE data does not prove testosterone therapy is unsafe. It proves that testosterone therapy is safe when prescribed to the right patients with proper monitoring. That distinction matters enormously. The men in TRAVERSE were diagnosed through rigorous clinical criteria, had comprehensive baseline labs, and were monitored throughout the trial. Remove those safeguards, and you are no longer practicing within the evidence base that TRAVERSE established.
How iRevive Approaches Telehealth Hormone Optimization
At iRevive, we built our practice on a simple principle: telehealth should make excellent care more accessible, not make mediocre care easier to deliver.
Ryan Hentges, FMNP-C, is the founding clinician and the provider you work with from your first call through every follow-up. Not a rotating roster. Not a call center. When you text Ryan at 8 PM with a question about your protocol, Ryan is the one who responds. That kind of access and continuity is what separates a concierge practice from a prescription factory.
Every iRevive patient starts with a comprehensive biomarker analysis drawn at a local lab, followed by a thorough review call where your results are discussed in detail and your personalized protocol is built from the ground up. Follow-up labs are built into the process, not treated as an optional add-on. The $99 per month membership covers your ongoing care, labs, and direct access to your provider.
We use telehealth because it removes barriers. You do not need to take a half-day off work to sit in a waiting room for a 10-minute appointment. You do not need to live within driving distance of a specialized clinic. You get the same clinical rigor, delivered with the flexibility that modern life demands.
But we will not prescribe hormones to someone who does not need them, no matter how convenient that might be. If your labs come back normal and your symptoms point to something else, we will tell you that. We will help you figure out what is actually going on. That is not lost revenue. That is medicine practiced correctly.
Frequently Asked Questions
Is online hormone therapy safe?
Online hormone therapy can be safe when the clinic follows the same clinical standards as any reputable medical practice. That means comprehensive lab work before prescribing, ongoing monitoring with follow-up labs, and a consistent provider managing your care. The delivery method (telehealth versus in-office) is less important than whether the clinic performs a proper clinical evaluation before writing a prescription.
How do I know if an online HRT clinic is legitimate?
Look for three things: whether they require comprehensive lab work before prescribing (not just a questionnaire), whether you see the same provider consistently, and whether follow-up labs are built into the treatment protocol. A legitimate clinic will also be transparent about pricing, use USA-sourced compounds, and have licensed medical professionals managing your care. If a clinic offers to prescribe hormones based on symptoms alone, that is a significant red flag.
What lab work should be done before starting hormone therapy?
A comprehensive biomarker panel should include at minimum: total and free testosterone, estradiol, SHBG, complete blood count (including hematocrit), comprehensive metabolic panel, lipid panel, thyroid function (TSH, free T3, free T4), PSA for men, and progesterone and DHEA-S for women. Some providers also test insulin, cortisol, vitamin D, and inflammatory markers depending on the clinical picture. Any clinic that prescribes without this baseline data is practicing below the standard of care.
Can hormone therapy cause blood clots or cardiovascular problems?
Testosterone therapy can cause polycythemia, a condition where the body produces too many red blood cells, which increases the risk of blood clots and cardiovascular events. Research published in the Journal of Urology found this risk is significant in the first year of therapy. However, the 2023 TRAVERSE trial showed that properly monitored testosterone therapy in men with confirmed hypogonadism did not increase major cardiovascular events. The key factor is monitoring: regular blood work catches polycythemia early so the protocol can be adjusted before complications arise.
How often should I have follow-up labs during hormone therapy?
Follow-up labs should be drawn at 6 to 8 weeks after starting therapy, then again at 12 weeks. After that, most patients transition to labs every 6 months. These follow-up panels check not just hormone levels but also hematocrit, liver function, metabolic markers, and other indicators that help your provider adjust your protocol safely. Clinics that do not require follow-up labs are cutting a critical safety corner.
What is the difference between a telehealth hormone clinic and a concierge hormone practice?
A telehealth hormone clinic simply delivers care remotely. That can range from a thorough, personalized service to a high-volume operation that pushes prescriptions with minimal evaluation. A concierge hormone practice, whether telehealth or not, emphasizes continuity of care with a dedicated provider, comprehensive lab work, ongoing monitoring, and direct access to your clinician for questions between visits. The concierge model prioritizes the patient relationship; the high-volume model prioritizes throughput.
Why did 6 out of 7 online clinics prescribe testosterone to someone who did not need it?
A study led by Northwestern University found that 6 out of 7 online testosterone clinics prescribed to an undercover urologist with normal testosterone levels (675 ng/dL) who also expressed a desire for future children. The likely reason is a business model that incentivizes prescribing over clinical evaluation. When revenue depends on converting consultations into prescriptions, the threshold for prescribing drops. This is why patients need to evaluate any clinic’s process carefully before starting treatment.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Hormone therapy should be initiated and managed under the supervision of a qualified healthcare provider based on comprehensive lab work and clinical evaluation. Individual results vary. Always consult your healthcare provider before starting or changing any medical treatment.
References
1. Dubin JM, et al. “An Investigation of Online Direct-to-Consumer Testosterone Prescribing in the US.” JAMA Internal Medicine, 2022. Covered by SMSNA and CBS News.
2. STAT News. “Why men are flocking to dubious online clinics for testosterone therapy.” November 21, 2025.
3. Ohlander SJ, et al. “Testosterone replacement therapy in the era of telemedicine.” International Journal of Impotence Research, 2021.
4. Nackeeran S, et al. “Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy.” Journal of Urology, 2022.
5. Lincoff AM, et al. “Cardiovascular Safety of Testosterone-Replacement Therapy.” New England Journal of Medicine, 2023. (TRAVERSE Trial)
6. CBS News. “Telehealth websites promise cure for ‘male menopause’ despite FDA ban on off-label ads.” 2023.
7. PLOS ONE. “Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018-2022.” 2024.
